"The FDA approval of Optune Pax marks the first new treatment in decades for people living with locally advanced pancreatic cancer," said Frank Leonard, CEO of Novocure. "Optune Pax is a fundamentally ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
The "Chemotherapy Induced Peripheral Neuropathy Treatment Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The market for Chemotherapy-Induced Peripheral ...
Please provide your email address to receive an email when new articles are posted on . WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Joan Stauffer, director of marketing ...
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease (PD) and anti-tau therapies, which are ...
When it comes to developing new cancer treatments, too often teams are focused on finding the treatment that most effectively kills tumours. But that’s only part of the goal, argues Immuneering CEO ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results